miR-1181 inhibits stem cell-like phenotypes and suppresses STAT3 in human pancreatic cancer [88], whilst miR-7 indirectly inhibits STAT3 and thereby decreases the number of breast cancer stem cells [89]. Here, STAT3 is linked to breast cancer.